News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
751,842 Results
Type
Article (56008)
Company Profile (289)
Press Release (695545)
Section
Business (215708)
Career Advice (2941)
Deals (37128)
Drug Delivery (116)
Drug Development (85869)
Employer Resources (184)
FDA (17216)
Job Trends (15886)
News (366203)
Policy (35359)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (6)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (6)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2896)
Accelerated approval (3)
Adcomms (29)
Allergies (87)
Alliances (53364)
ALS (93)
Alzheimer's disease (1441)
Antibody-drug conjugate (ADC) (133)
Approvals (17189)
Artificial intelligence (276)
Autoimmune disease (20)
Automation (14)
Bankruptcy (387)
Best Places to Work (12199)
BIOSECURE Act (20)
Biosimilars (110)
Biotechnology (200)
Bladder cancer (65)
Brain cancer (27)
Breast cancer (267)
Cancer (2124)
Cardiovascular disease (183)
Career advice (2464)
Career pathing (33)
CAR-T (158)
Cell therapy (439)
Cervical cancer (19)
Clinical research (69291)
Collaboration (821)
Compensation (464)
Complete response letters (27)
COVID-19 (2819)
CRISPR (41)
C-suite (226)
Cystic fibrosis (104)
Data (1993)
Decentralized trials (2)
Denatured (17)
Depression (50)
Diabetes (271)
Diagnostics (6681)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (46)
Drug discovery (131)
Drug pricing (118)
Drug shortages (30)
Duchenne muscular dystrophy (90)
Earnings (88935)
Editorial (38)
Employer branding (22)
Employer resources (157)
Events (117849)
Executive appointments (678)
FDA (18376)
Featured Employer (51)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (735)
Gene editing (106)
Generative AI (26)
Gene therapy (313)
GLP-1 (795)
Government (4832)
Grass and pollen (4)
Guidances (48)
Healthcare (20142)
Huntington's disease (24)
IgA nephropathy (25)
Immunology and inflammation (124)
Indications (27)
Infectious disease (2967)
Inflammatory bowel disease (143)
Inflation Reduction Act (9)
Influenza (50)
Intellectual property (89)
Interviews (551)
IPO (16998)
IRA (45)
Job creations (4139)
Job search strategy (2050)
Kidney cancer (10)
Labor market (35)
Layoffs (513)
Leadership (20)
Legal (8682)
Liver cancer (76)
Lung cancer (313)
Lymphoma (137)
Machine learning (4)
Management (62)
Manufacturing (297)
MASH (66)
Medical device (14117)
Medtech (14122)
Mergers & acquisitions (20605)
Metabolic disorders (702)
Multiple sclerosis (76)
NASH (23)
Neurodegenerative disease (98)
Neuropsychiatric disorders (31)
Neuroscience (1974)
NextGen: Class of 2025 (7144)
Non-profit (4906)
Northern California (2469)
Now hiring (37)
Obesity (380)
Opinion (269)
Ovarian cancer (75)
Pain (89)
Pancreatic cancer (79)
Parkinson's disease (141)
Partnered (20)
Patents (219)
Patient recruitment (97)
Peanut (51)
People (60424)
Pharmaceutical (72)
Pharmacy benefit managers (20)
Phase I (21516)
Phase II (30339)
Phase III (22837)
Pipeline (1065)
Podcasts (72)
Policy (126)
Postmarket research (2873)
Preclinical (9246)
Press Release (72)
Prostate cancer (97)
Psychedelics (35)
Radiopharmaceuticals (261)
Rare diseases (396)
Real estate (6528)
Recruiting (70)
Regulatory (23948)
Reports (48)
Research institute (2578)
Resumes & cover letters (471)
Rett syndrome (3)
RNA editing (4)
RSV (47)
Schizophrenia (76)
Series A (127)
Series B (83)
Service/supplier (14)
Sickle cell disease (56)
Southern California (2149)
Special edition (16)
Spinal muscular atrophy (161)
Sponsored (33)
Startups (3897)
State (2)
Stomach cancer (16)
Supply chain (65)
The Weekly (52)
United States (21897)
Vaccines (755)
Venture capitalists (39)
Webinars (12)
Weight loss (272)
Women's health (33)
Worklife (18)
Date
Today (240)
Last 7 days (761)
Last 30 days (2881)
Last 365 days (35583)
2025 (8620)
2024 (36937)
2023 (41638)
2022 (52950)
2021 (57651)
2020 (56507)
2019 (49721)
2018 (37696)
2017 (34584)
2016 (34432)
2015 (40408)
2014 (34126)
2013 (31891)
2012 (31507)
2011 (32134)
2010 (30396)
Location
Africa (946)
Alabama (50)
Alaska (7)
Arizona (241)
Arkansas (14)
Asia (42865)
Australia (7267)
California (5669)
Canada (1892)
China (499)
Colorado (253)
Connecticut (277)
Delaware (130)
Europe (94282)
Florida (843)
Georgia (196)
Idaho (63)
Illinois (530)
India (24)
Indiana (302)
Iowa (9)
Japan (145)
Kansas (104)
Kentucky (26)
Louisiana (8)
Maine (61)
Maryland (872)
Massachusetts (4311)
Michigan (214)
Minnesota (381)
Mississippi (2)
Missouri (78)
Montana (30)
Nebraska (25)
Nevada (57)
New Hampshire (67)
New Jersey (1624)
New Mexico (31)
New York (1629)
North Carolina (1009)
North Dakota (8)
Northern California (2469)
Ohio (197)
Oklahoma (15)
Oregon (36)
Pennsylvania (1275)
Puerto Rico (9)
Rhode Island (26)
South America (1341)
South Carolina (19)
South Dakota (1)
Southern California (2149)
Tennessee (95)
Texas (844)
Utah (171)
Virginia (136)
Washington D.C. (62)
Washington State (526)
West Virginia (3)
Wisconsin (57)
751,842 Results for "si bone inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2024 and Issues 2025 Guidance
February 25, 2025
·
10 min read
Business
SI-BONE, Inc. Reports Financial Results for the First Quarter 2024
SI-BONE, Inc., a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, reported financial results for the quarter ended March 31, 2024.
May 6, 2024
·
8 min read
Press Releases
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2024
January 14, 2025
·
4 min read
Press Releases
SI-BONE to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 24, 2025
February 3, 2025
·
1 min read
Press Releases
SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates Guidance
November 13, 2024
·
9 min read
Biotech Bay
SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming 2024 Truist Securities MedTech Conference in Boston.
June 5, 2024
·
1 min read
Biotech Bay
SI-BONE To Present at BofA Securities 2024 Healthcare Conference on May 14, 2024
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming 2024 BofA Securities Healthcare Conference in Las Vegas.
April 29, 2024
·
1 min read
Biotech Bay
SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures
SI-BONE, Inc. announced the first cases completed with the smaller, 9.5 mm diameter, iFuse Bedrock Granite® Implant.
May 7, 2024
·
3 min read
Business
SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy today announced it will report financial results for the first quarter of 2024 after market close on Monday, May 6, 2024.
April 15, 2024
·
1 min read
Business
SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the fourth quarter and full year ended December 31, 2023.
February 26, 2024
·
11 min read
1 of 75,185
Next
